These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32391047)

  • 1. Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma.
    Liao Y; Wang Y; Cheng M; Huang C; Fan X
    Front Genet; 2020; 11():311. PubMed ID: 32391047
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioinformatics Analysis Reveals Biomarkers With Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma.
    Liao Y; Xiao H; Cheng M; Fan X
    Front Genet; 2020; 11():427. PubMed ID: 32528520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
    Chen M; Wang X; Wang W; Gui X; Li Z
    Front Immunol; 2022; 13():829057. PubMed ID: 35833114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma.
    Hou S; Xu H; Liu S; Yang B; Li L; Zhao H; Jiang C
    Front Genet; 2022; 13():860268. PubMed ID: 35464867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
    Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
    Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H
    Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma.
    Zhang H; Cao C; Xiong H
    Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in kidney renal clear cell carcinoma.
    Zhang Z; Xiong X; Zhang R; Xiong G; Yu C; Xu L
    Transl Androl Urol; 2021 Aug; 10(8):3501-3514. PubMed ID: 34532274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
    Dai D; Shi R; Han S; Jin H; Wang X
    Medicine (Baltimore); 2020 Aug; 99(32):e21478. PubMed ID: 32769881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.
    Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY
    Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma.
    Wang X; Luo X; Wang Z; Wang Y; Zhao J; Bian L
    Heliyon; 2023 Sep; 9(9):e19114. PubMed ID: 37662825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Six Prognostic Genes in EGFR-Mutant Lung Adenocarcinoma Using Structure Network Algorithms.
    Zhang H; Lu D; Li Q; Lu F; Zhang J; Wang Z; Lu X; Wang J
    Front Genet; 2021; 12():755245. PubMed ID: 34868228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.
    Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R
    Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis.
    Dodin Y
    Medicine (Baltimore); 2023 Nov; 102(46):e36084. PubMed ID: 37986325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.
    Pan S; Zhan Y; Chen X; Wu B; Liu B
    Front Oncol; 2019; 9():613. PubMed ID: 31334127
    [No Abstract]   [Full Text] [Related]  

  • 17. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
    Deng H; Hang Q; Shen D; Zhang Y; Chen M
    Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
    Pei J; Wang Y; Li Y
    J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside.
    Wang X; Xiao Z; Gong J; Liu Z; Zhang M; Zhang Z
    Transl Lung Cancer Res; 2021 Jan; 10(1):167-182. PubMed ID: 33569302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.